Carraguard microbicide fails to stop HIV
HIV prevention was dealt another blow yesterday with the announcement that a vaginal gel based on seaweed had no affect on blocking HIV transmission.
Trials of the microbicide called Carraguard involved some 6 000 South African women in Durban, Cape Town and Tshwane.
While the gel was found to be safe for vaginal use for up to two years, ‘it was not effective for HIV prevention,’ the US-based Population Council announced.
While the council said it was disappointed that the gel showed no effect on HIV, it was already working on a new candidate microbicide that would use Carraguard as a base for an antiretroviral drug called MIV150.
However, the Popultion Council said that there had been a number of positive spin-offs for those who had taken part in the trial, primarily that the rate of condom used had doubled and the rate of sexually transmitted infections had plummeted.
This they ascribed to HIV/AIDS education and to regular medical check-ups.
Meanwhile, Health Minister Manto Tshabalala-Msimang was briefed on the results of the trial yesterday.
“The continued inability of these products to deliver the desired outcomes poses a serious challenge. While there is an urgent need for innovation, how do we maintain the public confidence in the possibility for success amid the many setbacks affecting HIV prevention research,” said Tshabalala-Msimang.
The failure of the Carraguard follows the recent failure of another microbicide called cellulose sulphate. This trial was suspended after more women in the trial arm than the control group became HIV positive.
The development of microbicides is now focused on so-called third generation microbicides containing antiretroviral medication.
The Centre for AIDS Policy and Research in SA (Caprisa) is currently preparing for the trial of a microbicide containing tenofivir.’Health-e News Service.
Author
-
Kerry Cullinan is the Managing Editor at Health-e News Service. Follow her on Twitter @kerrycullinan11
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Carraguard microbicide fails to stop HIV
by Kerry Cullinan, Health-e News
February 19, 2008
Related
Medicine price transparency is a sticky issue at WHA
The World Health Assembly reports that universal health coverage is gaining momentum, but many governments are intent on keeping their medicine prices secret.
Coke denies sugar cut linked to tax
Coca-Cola South Africa denies that it cut the sugar content of its drinks in response to government’s tax on sugary drinks.
#SAElections2019: Should Motsoaledi stay?
Passionate and principled, the Health Minister has led massive victories over HIV during the past decade. But as South Africa attempts to introduce complex changes to our health system, is it time for an operations person rather than a firefighter?